Changes in medical cannabis use in Ontario, Canada (2014 to 2019) Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization

被引:0
|
作者
Imtiaz, Sameer [1 ]
Nigatu, Yeshambel T. [1 ]
Ali, Farihah [1 ]
Elton-Marshall, Tara [1 ,2 ]
Rehm, Juergen [3 ,4 ,5 ,6 ,7 ,8 ]
Rueda, Sergio [4 ,5 ]
Hamilton, Hayley A. [3 ,4 ]
机构
[1] Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, 2035B 33 Russell St, Toronto, ON M5S 2S1, Canada
[2] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, 600 Peter Morand Crescent, Ottawa, ON K1G 5Z3, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, 6th Floor, 155 Coll St, Toronto, ON M5T 3M7, Canada
[4] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, 250 Coll St, Toronto, ON M5T 1R8, Canada
[5] Univ Toronto, Inst Med Sci, Room 2374, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[6] Univ Toronto, Dept Psychiat, 8th Floor, 250 Coll St, Toronto, ON M5T 1R8, Canada
[7] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Chemnitzer Str 46, D-01187 Dresden, Germany
[8] IM Sechenov First Moscow State Med Univ, Inst Leadership & Hlth Management, Dept Int Hlth Projects, Trubetskaya Str, 8, B 2, Moscow 119992, Russia
基金
加拿大健康研究院;
关键词
Canada; Cannabis; Marijuana use; Marijuana smoking; Medical use; Policy;
D O I
10.1016/j.pmedr.2024.102805
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: We characterized trends in medical cannabis use; examined characteristics associated with medical cannabis use without medical authorization; and examined the association between recreational cannabis legalization and medical cannabis use in Ontario, Canada. Methods: Data were from a repeated, population-based, cross-sectional survey of adults (N = 19,543; 2014-2019). Cannabis use was categorized as either medical cannabis use, recreational cannabis use or no cannabis use. The analytical strategy included jointpoint regression, logistic regression and multinomial logistic regression. Results: Medical cannabis use increased from 4 % to 11 % (Annual Percentage Change [APC]: 25 %, 95 % Confidence Interval [CI]: 17 %-33 %) and recreational cannabis use increased from 9 % to 15 % (APC: 9 %, 95 % CI: 3 %-15 %) between 2014 and 2019. Being 18 to 29 years old compared with being 65+ years old was associated with an increased likelihood of medical cannabis use without medical authorization (Odds Ratio [OR]: 4.05, 95 % CI: 2.12-7.72), while being of fair or poor self-perceived health compared with excellent, very good or good self-perceived health (OR: 0.61, 95 % CI: 0.40-0.95) was associated with a decreased likelihood of medical cannabis use without medical authorization. Recreational cannabis legalization was associated with an increased likelihood of medical cannabis use compared with no cannabis use (OR: 1.48, 95 % CI: 1.19-1.85) and of recreational cannabis use compared with no cannabis use (OR: 1.35, 95 % CI: 1.11-1.65). Conclusions: Although medical cannabis use increased, it was largely used without medical authorization. Guidance and education that encourages medical usage under clinical supervision is recommended, and mitigation of known barriers to medical cannabis authorization.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada
    Nguyen, Hai V.
    Grootendorst, Paul
    Mital, Shweta
    Bishop, Lisa
    McGinty, Emma E.
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2024, 9 (01) : 335 - 342
  • [2] Legalization of cannabis for medical and recreational use
    Hasin, D.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [3] Legalization of cannabis for medical and recreational use
    Hasin, D.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [4] Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status
    Balneaves, Lynda G.
    Brown, Ashleigh
    Green, Matthew
    Prosk, Erin
    Rapin, Lucile
    Monahan-Ellison, Max
    Mcmillan, Eva
    Zaid, Jonathan
    Dworkind, Michael
    Watling, Cody Z.
    [J]. BMC MEDICINE, 2024, 22 (01) : 150
  • [5] A Description of the Medical Cannabis Use in Ontario, Canada
    Eurich, Dean T.
    Hanlon, John G.
    Boisvenue, Jamie J.
    Meng, Howard
    Dyck, Jason R. B.
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2019, 4 (02) : 131 - 135
  • [6] Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001-2019)
    Imtiaz, Sameer
    Nigatu, Yeshambel T.
    Ali, Farihah
    Douglas, Laura
    Hamilton, Hayley A.
    Rehm, Jurgen
    Rueda, Sergio
    Schwartz, Robert M.
    Wells, Samantha
    Elton-Marshall, Tara
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2023, 244
  • [7] Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality
    Nguyen, Hai V.
    McGinty, Emma E.
    Mital, Shweta
    Alexander, G. Caleb
    [J]. JAMA HEALTH FORUM, 2024, 5 (01): : E234897
  • [8] Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
    Myran, Daniel Thomas
    Roberts, Rhiannon
    Pugliese, Michael
    Taljaard, Monica
    Tanuseputro, Peter
    Pacula, Rosalie Liccardo
    [J]. JAMA NETWORK OPEN, 2022, 5 (09) : E2231937
  • [9] Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study
    Das, Ankita
    Hendershot, Christian S.
    Husain, M. Ishrat
    Knyahnytska, Yuliya
    Elsaid, Sonja
    Le Foll, Bernard
    Kloiber, Stefan
    [J]. PHARMACOPSYCHIATRY, 2024, 57 (03) : 141 - 151
  • [10] Potential harms from legalization of recreational cannabis use in Canada
    Sarah B. Windle
    Kristina Wade
    Kristian B. Filion
    Jonathan Kimmelman
    Brett D. Thombs
    Mark J. Eisenberg
    [J]. Canadian Journal of Public Health, 2019, 110 : 222 - 226